Q32 Bio to participate in upcoming September investor conferences
Q32 Bio Inc. said management will participate in upcoming September investor conferences. The company is focused on developing therapies for alopecia areata and other autoimmune and inflammatory diseases.
WALTHAM, Mass., Sept.
1, 2026 // -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata ("AA") and other autoimmune and inflammatory diseases, today announced that management will participate in thr…